Giavridis et al. demonstrated the impact of the CD40L-CD40R interaction in a xenografted immunodeficient mouse model, where the intensity of CRS symptoms was enhanced when CD19-directed human CAR T cells were engineered to express murine CD40L. The gene discussed is CD19; the disease is congenital rubella syndrome.